Redox-Dependent Mechanisms in Coronary Collateral Growth: The “Redox Window” Hypothesis
- 1 August 2009
- journal article
- research article
- Published by SAGE Publications in Antioxidants & Redox Signaling
- Vol. 11 (8) , 1961-1974
Abstract
This review addresses the complexity of coronary collateral growth from the aspect of redox signaling and introduces the concept of a “redox window” in the context of collateral growth. In essence, the redox window constitutes a range in the redox state of cells, which not only is permissive for the actions of growth factors but also amplifies their actions. The interactions of redox-dependent signaling with growth factors are well established through the actions of many redox-dependent kinases ( e.g ., Akt and p38 mitogen-activated protein kinase). The initial changes in cellular redox can be induced by a variety of events, from the oxidative burst during reperfusion after ischemia, to recruitment of various types of inflammatory cells capable of producing reactive oxygen species. Any event that “upsets” the normal redox equilibrium is capable of amplifying growth. However, extremes of the redox window, oxidative and reductive stresses, are associated with diminished growth-factor signaling and reduced activation of redox-dependent kinases. This concept of a redox window helps to explain why the clinical trials aimed at stimulating coronary collateral growth, the “therapeutic angiogenesis trials,” failed. However, understanding of redox signaling in the context of coronary collateral growth could provide new paradigms for stimulating collateral growth in patients. Antioxid. Redox Signal. 11, 1961–1974.Keywords
This publication has 123 references indexed in Scilit:
- Vascular Endothelial Growth Factor-A Specifies Formation of Native Collaterals and Regulates Collateral Growth in IschemiaCirculation Research, 2008
- Ischemia Is Not Required for Arteriogenesis in Zebrafish EmbryosArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular diseaseGene Therapy, 2007
- VEGFR1 (Flt-1+/−) gene knockout leads to the disruption of VEGF-mediated signaling through the nitric oxide/heme oxygenase pathway in ischemic preconditioned myocardiumFree Radical Biology and Medicine, 2007
- The delay of contrast arrival in magnetic resonance first-pass perfusion imaging: a novel non-invasive parameter detecting collateral-dependent myocardiumHeart, 2007
- Metabolic profiling of livers and blood from obese Zucker ratsJournal of Hepatology, 2006
- Cardiac Ischemic Score Determines the Presence of Coronary Collateral CirculationCardiovascular Drugs and Therapy, 2005
- Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cellsJournal of Cancer Research and Clinical Oncology, 2004
- NAD(P)H Oxidase-Derived Reactive Oxygen Species as Mediators of Angiotensin II SignalingAntioxidants & Redox Signaling, 2002
- Changes in coronary flow following repeated brief coronary occlusion in the conscious dogHeart and Vessels, 1986